Última actualización :
03/07/2025
Los equipos de investigación - Quality Evaluation Team, Samsung Bioepis Co   pdf  
Japón
Laboratorio farmacéutico
Quality Evaluation Team, Samsung Bioepis Co
Incheon
Bibliografía   Bibliografía   (5)  
1
In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period.
Tak M, Jeong H, Yun J, Kim J, Kim S, Lee Y, Park S-J. (sujin8171.park@samsung.com)
Drugs R D - 2023 - ;23,4:363 - 375
2
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration.
Kaiser P.K, Yun J, Kim S, Kim J, Park S.J. (sujin8171.park@samsung.com)
Ophtalmol Ther - 2023 - ; 12:985–998.
3
4
Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties
Yun J, Kim J, Chung J, Hwang S-J, Park S-J. (sujin8171.park@samsung.com)
Adv Ther - 2019 -
5
Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature.
Park D, Yun J, Hwang S-J, Park SJ. (sujin8171.park@samsung.com)
Adv Ther - 2019 - 36:442–450

Lista de la molécula   moléculas estudiadas   (5)  
Inmunosupresor Inyectables Adalimumab
fármacos contra el cáncer Inyectables Bevacizumab
Varios Inyectables Eculizumab
Varios Inyectables Ranibizumab
fármacos contra el cáncer Inyectables Trastuzumab

  Mentions Légales
BESbswy